NET PROFIT (x1000 EUR)
Orion Pharma AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
496
|
871
|
183 |
| Total assets |
2,319
|
2,181
|
1,460 |
| Current assets |
2,231
|
2,083
|
1,352 |
| Current liabilities |
1,938
|
1,236
|
976 |
| Equity capital |
379
|
944
|
483 |
| - share capital |
71
|
76
|
80 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
16.3%
|
43.3%
|
33.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
21.4%
|
39.9%
|
12.5% |
| Current ratio |
115.1%
|
168.5%
|
138.5% |
| Return on equity (ROE) |
130.9%
|
92.3%
|
37.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.